Username:  
Password:  
Focal Point Login
 Home  Meetings References Search for Events Search for Experts

View the event

Reference:3993
Country:Tajikistan
Multiple country event:No
Project: Not Specified
Region:EURO
City:Dushanbe
Start date:2 April 2012
End date:6 April 2012
Estimated duration (days):5
Status:Completed - Complété
 (The mission has taken place)

Title:GDF mission (combined with GLC and GF)
Preferred event date:
Type: Mission - GLC
Mission - Grant Monitoring
Terms of Reference:The objectives of the mission are to (for GDF part):
• review GDF support with key officials;
• assess adherence to GDF terms and conditions of support;
• provide technical support for programme management, case management, and drug
management;
• determine, together with the National TB Control Programme, the drug needs and
prepare the drug request for the coming year; and
• address issues raised by GDF Technical Review Committee (TRC) or during
previous missions.
and (for GLC/Europe part)
Objectives:
• to assess the implementation of the program, evaluate current achievements and sustainability of the program; and develop recommendations for future activities;
• to assess the National M/XDR-TB Response Plan and ensure that it complies with the European M/XDR-TB Response Plan;
• to assess the progress of the implementation of the National M/XDR-TB Response Plan (if available);
• to assess the current M/XDR–TB Control project supported by the Global Fund or any other donor (if applicable).
Key issues to be elaborated and reviewed:
1) Availability of the National M/XDR-TB Response Plan, which includes coverage of all patients including children and adolescents, prisoners and migrants, homeless and etc.;
2) Alignment of the National M/XDR-TB Response Plan to the “Consolidated Action Plan to Prevent and Combat M/XDR-TB in WHO European Region 2011 – 2015”;
3) Identify the need of technical assistance to elaborate and modify the National M/XDR-TB Response Plan;
4) Assess the level of the governmental support and coordination between government and internal and external partners (donors, implementers); the project and the community; civilian and penitentiary system; M/XDR-TB and HIV interventions; human resources management and training;
5) Assess case finding strategies and identify barriers to timely start of M/XDR-TB treatment, including TB in children;
6) Case management and treatment strategies and approaches (clinical protocols and guidelines, side effect management and availability of diagnostics and ancillary drugs at all levels, especially at ambulatory sector); TB children case management; TB care delivery ethics and other relevant aspects of the program with the focus on vulnerable groups (prisoners, former prisoners, migrants and children);
7) Follow up of TB and M/XDR-TB patients; patient-centered approach and social support;
8) Infection control strategies at inpatient and outpatient settings;
9) Current status of laboratory services, diagnostics, accessibility for the patients, including children; collaboration with the supranational reference laboratory;
10) Drug management system for first and second-line TB drugs in terms of quantification method, procurement, importation, storage, distribution and delivery to the patients, availability of children dosages formulation; collaboration with the first and second-line drug procurement agency;
11) Information system (including availability of recording and reporting forms, and data base) and data management (routine collection and cohort analysis); existence of separate MDR-TB register or user-friendly platform for separate data management from the all TB register. Existence of the laboratory information management module linked to MDR-TB and/or TB register.
12) Identify the need, frequency and duration of technical assistance to implement the National M/XDR-TB Response Plan.
Training Opportunity:No
Website:
Purpose 1:MDR-TB / XDR-TB
Purpose 2:Drug and commodities management
Purpose 3:Global Fund grant implementation
Other purpose:

Entered by:GDF
Partner 1:The Global Fund
Partner 2:
Partner 3:
Contact name:Elena Mochinova; Ogtay Gozalov
Contact email:mochinovae@who.int; ogo@euro.who.int
Other agencies: 

Funding needs:No
Funding source:GDF Unspecified
Other funding source:
Available funding:$ 0
Funding gap:$ 0
Global Fund reference: 

Comments:Mission combined with GLC and GF
 

Documents associated with this event

Mission Report - Rapport de la mission This document is not publicly available Confidential  

Experts (roster) associated with this event

Kai Blöndal kaivink@kodu.ee      

Experts (non-roster) associated with this event

  Philippe Creac'H mochinovae@who.int    
  Zhyldyz Ysykeeva mochinovae@who.int    

Date Created: 23 January 2012
Entered By: Lidvina Grand (GDF)




© World Health Organization 2013       Stop TB Partnership home page       Contact us